Skip to content

A Study on Integrated Monitoring Platform for Stress Based on Salivary Biomarkers and Artificial Intelligence Algorithms

A Study on Integrated Monitoring Platform for Stress Based on Salivary Biomarkers and Artificial Intelligence Algorithms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127760
Enrollment
Unknown
Registered
2026-07-07
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Interventions

Acute stress:None
Chronic stress:None
Healthy control:None
University students (art therapy):None
High-stress occupation:None

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Clinical scenarios Inclusion criteria: 1. At least 18 years old, with full civil capacity, clear awareness, able to understand the research content and cooperate in completing the assessment; 2. Acute Stress Group (ICD-11 ARS): professionally assessed by a psychiatrist, meeting the diagnostic criteria for "Acute Stress Reaction (ARS)" in the 11th edition of the International Classification of Diseases (ICD-11) (specific course requirements must be provided, such as symptoms occurring within hours to days after a recent major stress event, and duration meeting the ARS definition); 3. Chronic Stress Group (ICD-11 PTSD/Depression/Anxiety): Professionally assessed by a psychiatrist and meeting any of the following diagnostic criteria in ICD-11: Post-Traumatic Stress Disorder (PTSD); Depressive Disorders; Anxiety Disorders; It is necessary to clarify the course of the disease, such as symptoms lasting at least X weeks/month and currently in the flare-up phase or not yet in remission; 4. Health control group: assessed by a psychiatrist, with no history of mental disorders (including ICD-11 defined mental or behavioral disorders), and no significant psychological distress (e.g., no depression/anxiety symptoms or symptom levels below clinical threshold confirmed by standardized screening tools); 5. Voluntarily participate in this study, sign a written informed consent form, and be able to understand and independently complete the required questionnaires (or with family assistance; if the subject has mild cognitive impairment but is determined by a physician not to affect core assessment). 2. Student scenarios Inclusion criteria: 1. Full-time university students aged 18 or above; 2. Voluntarily participate in this study and sign the informed consent form, able to understand and complete the questionnaire.

Exclusion criteria

Exclusion criteria: 1. Clinical scenarios Exclusion criteria: 1. History of severe mental illness: Current or past clearly diagnosed severe mental illness, including but not limited to: (1) Major depressive disorder with psychotic symptoms, bipolar disorder type I/II (current or past manic/depressive episodes), schizophrenia spectrum and other psychotic disorders (corresponding to ICD-11 codes); (2) Other mental disorders that may cause severe cognitive impairment or inability to cooperate with assessments (such as organic mental disorders, delirium, etc.); 2. Medication interference: Systematically taking the following medications within the past month that may affect stress responses or psychological assessment results: (1) Antidepressants (such as SSRIs, SNRIs, tricycloids, etc.); (2) Anti-anxiety drugs (such as benzodiazepines, buspirone, etc.); (3) Glucocorticoids (such as prednisone, dexamethasone, etc., as they may affect mood and stress physiological indicators); If the subject has taken the above drugs but stopped for more than one month, they may be considered after a physician's assessment that the drug residue effect has been eliminated; 3. Severe or unstable physical diseases, including but not limited to: endocrine diseases, autoimmune diseases, cardiovascular diseases (recent relevant examination reports must be provided; if the subject's physical condition is stable and confirmed by a specialist that does not affect psychological assessment, the investigator may decide whether to include them); 4. History of alcohol dependence, drug abuse (such as marijuana, opioids, stimulants, etc.), or alcohol/substance abuse within the past 6 months; 5. Pregnant or breastfeeding women; 6. Severe cognitive impairment that prevents understanding the scale content or cooperating with the assessment. 2. Student scenarios Exclusion criteria: 1. Current or past history of major depressive disorder, bipolar disorder, schizophrenia, or other serious mental illnesses with a clear diagnosis; 2. Systematic use of antidepressants, anxiolytics, or glucocorticoids within the past month; 3. Severe or unstable physical illnesses (such as endocrine diseases, autoimmune diseases, cardiovascular diseases); 4. History of alcohol or substance abuse; 5. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Salivary cortisol ;epinephrine;norepinephrine;Cortisol awakening response; instantaneous fluctuation rate;Self Rating Depression Scale;Self?Rating Anxiety Scale;Perceived Stress Scale; accuracy of the AI model;

Secondary

MeasureTime frame
E/NE ratio;E/cortisol ratio;

Countries

China

Contacts

Public ContactZhang Chunyan

Chinese PLA General Hospital

rebrcca@126.com+86 188 1088 2866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026